Latest News and Press Releases

Roche's investigational Port Delivery System with ranibizumab (PDS) is intended to reduce the burden of frequent eye injections for people with neovascular age-related macular degeneration (nAMD)...

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Emmen, Switzerland, July 26, 2018 ALSO achieved...

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Group sales increase 7%[1] at...

LONDON, 26 Jul. 2018 (GLOBE NEWSWIRE) -- This is the Start of Day Message for GlobeNewswire. GlobeNewswire is operated by Nasdaq Corporate Solutions and is designated by the FCA as an approved...

Group sales increase 7%[1] at constant exchange rates and in Swiss francs Pharmaceuticals Division sales up 7%, driven mainly by Ocrevus, Perjeta, Alecensa and Tecentriq Diagnostics Division...

Organic revenue growth, margin improvement and strong cash flow Second quarter highlights: Organic increase operating EBITA of 6% to €45 million, resulting in operating EBITA margin of 7.4% (Q2...

Nokia Corporation Half Year Financial Report July 26, 2018 at 08:00 (CET +1) Nokia Corporation Financial Report for Q2 and Half Year 2018 First half 2018 as expected; improvement expected in...

H1 2018 results Adjusted revenue down -0.5% to €1,643.3 million Adjusted organic revenue up +4.0%, with an accelerating Q2 at +4.9% Adjusted operating margin of €214.4 million, down -15.9% ...

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} press release First-half 2018 earnings...

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;}  Pixium Vision announces H1 2018...